Fractyl Health, Inc.
GUTS
$1.10
$0.010.92%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | 3.00K | 14.00K | 43.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | 3.00K | 14.00K | 43.00K |
| Cost of Revenue | -- | -- | 0.00 | 7.00K | 24.00K |
| Gross Profit | -- | -- | 3.00K | 7.00K | 19.00K |
| SG&A Expenses | 4.93M | 5.32M | 4.93M | 4.80M | 6.24M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 26.08M | 24.76M | 25.21M | 23.81M | 23.03M |
| Operating Income | -26.08M | -24.76M | -25.21M | -23.79M | -22.99M |
| Income Before Tax | -27.89M | -23.74M | -24.97M | -23.17M | -17.23M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -27.89M | -23.74M | -24.97M | -23.17M | -17.23M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -27.89M | -23.74M | -24.97M | -23.17M | -17.23M |
| EBIT | -26.08M | -24.76M | -25.21M | -23.79M | -22.99M |
| EBITDA | -25.81M | -24.47M | -24.99M | -23.59M | -22.79M |
| EPS Basic | -0.57 | -0.49 | -0.52 | -0.48 | -0.36 |
| Normalized Basic EPS | -0.33 | -0.30 | -0.31 | -0.27 | -0.22 |
| EPS Diluted | -0.57 | -0.49 | -0.52 | -0.48 | -0.36 |
| Normalized Diluted EPS | -0.33 | -0.30 | -0.31 | -0.27 | -0.22 |
| Average Basic Shares Outstanding | 49.04M | 48.87M | 48.45M | 47.97M | 47.90M |
| Average Diluted Shares Outstanding | 49.04M | 48.87M | 48.45M | 47.97M | 47.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |